• SELECT SITE CURRENCY
Select a currency for use throughout the site
Nanoparticulate drug delivery: Perspectives on the transition from laboratory to market
Woodhead Publishing Ltd, October 2012, Pages: 250
Nanoparticulate drug delivery highlights and examines the transition of nanoparticulate drug delivery systems, operating at scales of billionths of a metre, from laboratory into a commercially viable sector. This has been a challenging journey, beginning in 2005 with the introduction of Abraxane, the first nanotechnology-based drug delivery product for the treatment of breast cancer, which marked the advent of nanotechnology in the pharmaceutical and healthcare industry. The book describes the need for various types of nanoparticulate drug delivery systems in different application areas, and assesses the challenges associated with their advance to society.
Particulate systems as drug carriers: the need
Particles as drug carriers
- Characterization techniques for nano
- Nanotoxicology: evaluating toxicity potential of drug-nano
- Regulatory aspects of nano
Particulate drug delivery systems
- Clinical trials and industrial aspects
- Case studies: nano-systems in the market.
Vandana Patravale is a Professor of Pharmaceutics at the Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India. Her research group is actively involved in the design and development of colloidal drug delivery systems for various routes including oral, topical, transdermal, nasal and parenteral.
Prajakta Dandekar is the first female Indian scientist to be award the European Respiratory Society – Marie Curie Joint Postdoctoral Fellowship and is currently a guest scientist at the Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany. Her research interests include the design of polymeric nanoparticles of novel polymers for application in siRNA delivery and gene therapy
Ratnesh Jain has been awarded the Alexander von Humboldt Postdoctoral Fellowship by the AvH Foundation and is currently a guest scientist at the Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany. His research interests include design of nanoparticles of commercial cationic polymers for application in siRNA delivery and gene therapy.